Selected Publications

• Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis.

Alkon N, Assen FP, Arnoldner T, Bauer WM, Medjimorec MA, Shaw LE, Rindler K, Holzer G, Weber P, Weninger W, Freystätter C, Chennareddy S, Kinaciyan T, Farlik M, Jonak C, Griss J, Bangert C, Brunner PM. J Allergy Clin Immunol. 2023 May 18:S0091-6749(23)00607-3. doi: 10.1016/j.jaci.2023.04.019.

• IgE Depletion With Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis.

Bangert C, Loesche C, Skvara H, Fölster-Holst R, Lacour JP, Jones J, Burnett P, Novak N, Stingl G. J Invest Dermatol. 2023 Mar 31:S0022-202X(23)01942-5. doi: 10.1016/j.jid.2023.01.040. Online ahead of print.

• Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen-specific IgE production.

Campion NJ, Doralt A, Lupinek C, Berger M, Poglitsch K, Brugger J, Quint T, Gangl K, Sinz C, Bartosik T, Liu DT, Landegger LD, Tu A, Stanek V, Berger U, Bangert C, Schneider S, Eckl-Dorna J. Allergy. 2023 Jun;78(6):1687-1691. doi: 10.1111/all.15653. Epub 2023 Feb 3.

• Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.

Schneider S, Poglitsch K, Morgenstern C, Quint T, Gangl K, Sinz C, Bartosik T, Campion NJ, Liu DT, Landegger LD, Tu A, Stanek V, Rocha-Hasler M, Bangert C, Eckl-Dorna J. Eur Respir J. 2023 Mar 16;61(3):2201335. doi: 10.1183/13993003.01335-2022. Print 2023 Mar.

• Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis.

Chromy D, Bartosik T, Brkic FF, Quint T, Tu A, Eckl-Dorna J, Schneider S, Bangert C. J Dermatol. 2023 Jan;50(1):89-93. doi: 10.1111/1346-8138.16595. Epub 2022 Sep 30.

• Multiple Drug Hypersensitivity in a Small Child with DRESS Syndrome - A Case Report.

Gruber S, Gona-Hoepler L, Bangert C, Diesner SC, Schmidthaler K, Szepfalusi Z. Klin Padiatr. 2023 Jan;235(1):52-54. doi: 10.1055/a-1857-5062. Epub 2022 Jul 4.

• Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.

Weiss A, Delavenne E, Matias C, Lagler H, Simon D, Li P, Hansen JU, Dos Santos TP, Jana B, Priemel P, Bangert C, Bauer M, Eberl S, Nussbaumer-Pröll A, Anne Österreicher Z, Matzneller P, Quint T, Weber M, Nielsen HM, Rades T, Johansen HK, Westh H, Kim W, Mylonakis E, Friis C, Guardabassi L, Pace J, Lundberg CV, M'Zali F, Butty P, Sørensen N, Nielsen HB, Toft-Kehler R, Guttman-Yassky E, Stingl G, Zeitlinger M, Sommer M. Clin Transl Med. 2022 May;12(5):e790. doi: 10.1002/ctm2.790.

• An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate-to-severe atopic dermatitis.

Werfel T, Irvine AD, Bangert C, Seneschal J, Grond S, Cardillo T, Brinker D, Zhong J, Riedl E, Wollenberg A. J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1486-1496. doi: 10.1111/jdv.18193. Epub 2022 May 18.

• Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease.

Bangert C, Villazala-Merino S, Fahrenberger M, Krausgruber T, Bauer WM, Stanek V, Campion NJ, Bartosik T, Quint T, Regelsberger G, Niederberger-Leppin V, Bock C, Schneider S, Eckl-Dorna J. Front Immunol. 2022 Mar 28;13:850494. doi: 10.3389/fimmu.2022.850494. eCollection 2022.

• Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis.

Schwarz C, Chromy D, Bangert C, Schwarz M, Jachs M, Reiberger T, Gschwantler M. J Hepatol. 2022 Jul;77(1):254-255. doi: 10.1016/j.jhep.2022.03.004. Epub 2022 Mar 16.

• Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis.

Lagler H, Bangert C, Quint T, Österreicher Z, Nussbaumer-Pröll A, Eberl S, Weber M, Karer M, Sommer MOA, Zeitlinger M. Eur J Clin Microbiol Infect Dis. 2022 Feb;41(2):245-252. doi: 10.1007/s10096-021-04365-5. Epub 2021 Nov 4.

• Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.

Quint T, Dahm V, Ramazanova D, Arnoldner MA, Kurz H, Janik S, Brunner PM, Knerer-Schally B, Weninger W, Griss J, Ristl R, Schneider S, Bangert C. J Allergy Clin Immunol Pract. 2022 Feb;10(2):506-516.e6. doi: 10.1016/j.jaip.2021.09.050. Epub 2021 Oct 20.

• The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.

Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, Ballmer-Weber B, Bangert C, Ben-Shoshan M, Bernstein JA, Bindslev-Jensen C, Brockow K, Brzoza Z, Chong Neto HJ, Church MK, Criado PR, Danilycheva IV, Dressler C, Ensina LF, Fonacier L, Gaskins M, Gáspár K, Gelincik A, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Grosber M, Hamelmann E, Hébert J, Hide M, Kaplan A, Kapp A, Kessel A, Kocatürk E, Kulthanan K, Larenas-Linnemann D, Lauerma A, Leslie TA, Magerl M, Makris M, Meshkova RY, Metz M, Micallef D, Mortz CG, Nast A, Oude-Elberink H, Pawankar R, Pigatto PD, Ratti Sisa H, Rojo Gutiérrez MI, Saini SS, Schmid-Grendelmeier P, Sekerel BE, Siebenhaar F, Siiskonen H, Soria A, Staubach-Renz P, Stingeni L, Sussman G, Szegedi A, Thomsen SF, Vadasz Z, Vestergaard C, Wedi B, Zhao Z, Maurer M. Allergy. 2022 Mar;77(3):734-766. doi: 10.1111/all.15090. Epub 2021 Oct 20.

• Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis.

Alkon N, Bauer WM, Krausgruber T, Goh I, Griss J, Nguyen V, Reininger B, Bangert C, Staud C, Brunner PM, Bock C, Haniffa M, Stingl G. J Allergy Clin Immunol. 2022 Feb;149(2):624-639. doi: 10.1016/j.jaci.2021.07.025. Epub 2021 Aug 5.

• Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.

Ring J, Worm M, Wollenberg A, Thyssen JP, Jakob T, Klimek L, Bangert C, Barbarot S, Bieber T, de Bruin-Weller MS, Chernyshov PV, Christen-Zaech S, Cork M, Darsow U, Flohr C, Fölster-Holst R, Gelmetti C, Gieler U, Gutermuth J, Heratizadeh A, Hijnen DJ, von Kobyletzki LB, Kunz B, Paul C, De Raeve L, Seneschal J, Simon D, Spuls PI, Stalder JF, Svensson A, Szalai Z, Taieb A, Torrelo A, Trzeciak M, Vestergaard C, Werfel T, Weidinger S, Deleuran M. J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3.

• Spontaneously Resolved Atopic Dermatitis Shows Melanocyte and Immune Cell Activation Distinct From Healthy Control Skin.

Rindler K, Krausgruber T, Thaler FM, Alkon N, Bangert C, Kurz H, Fortelny N, Rojahn TB, Jonak C, Griss J, Bock C, Brunner PM. Front Immunol. 2021 Feb 24;12:630892. doi: 10.3389/fimmu.2021.630892. eCollection 2021.

• European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.

Thyssen JP, Vestergaard C, Barbarot S, de Bruin-Weller MS, Bieber T, Taieb A, Seneschal J, Cork MJ, Paul C, Flohr C, Weidinger S, Trzeciak M, Werfel T, Heratizadeh A, Darsow U, Simon D, Torrelo A, Chernyshov PV, Stalder JF, Gelmetti C, Szalai Z, Svensson Å, von Kobyletzki LB, De Raeve L, Fölster-Holst R, Christen-Zaech S, Hijnen DJ, Gieler U, Gutermuth J, Bangert C, Spuls PI, Kunz B, Ring J, Wollenberg A, Deleuran M. J Eur Acad Dermatol Venereol. 2021 May;35(5):e308-e311. doi: 10.1111/jdv.17167. Epub 2021 Mar 7.

• Myostatin and markers of bone metabolism in dermatomyositis.

Kerschan-Schindl K, Gruther W, Föger-Samwald U, Bangert C, Kudlacek S, Pietschmann P. BMC Musculoskelet Disord. 2021 Feb 5;22(1):150. doi: 10.1186/s12891-021-04030-0.

• Persistence of mature dendritic cells, T_H2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade.

Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler FM, Kurz H, Ayub T, Demirtas D, Fortelny N, Vorstandlechner V, Bauer WM, Quint T, Mildner M, Jonak C, Elbe-Bürger A, Griss J, Bock C, Brunner PM. Sci Immunol. 2021 Jan 22;6(55):eabe2749. doi: 10.1126/sciimmunol.abe2749.

• Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.

Graier T, Salmhofer W, Jonak C, Weger W, Kölli C, Gruber B, Sator PG, Prillinger K, Mlynek A, Schütz-Bergmayr M, Richter L, Ratzinger G, Painsi C, Selhofer S, Häring N, Wippel-Slupetzky K, Skvara H, Trattner H, Tanew A, Inzinger M, Tatarski R, Bangert C, Ellersdorfer C, Lichem R, Gruber-Wackernagel A, Hofer A, Legat F, Schmiedberger E, Strohal R, Lange-Asschenfeldt B, Schmuth M, Vujic I, Hoetzenecker W, Trautinger F, Saxinger W, Müllegger R, Quehenberger F, Wolf P. Br J Dermatol. 2021 Jun;184(6):1094-1105. doi: 10.1111/bjd.19701. Epub 2021 Feb 22.

• Differences in men and women suffering from CRSwNP and AERD in quality of life.

Bartosik TJ, Liu DT, Campion NJ, Villazala-Merino S, Janik S, Dahm V, Mueller CA, Vyskocil E, Stanek V, Quint T, Bangert C, Eckl-Dorna J, Schneider S. Eur Arch Otorhinolaryngol. 2021 May;278(5):1419-1427. doi: 10.1007/s00405-020-06418-5. Epub 2020 Oct 15.

• Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis.

Quint T, Brunner PM, Sinz C, Steiner I, Ristl R, Vigl K, Kimeswenger S, Neubauer K, Pirkhammer D, Zikeli M, Hoetzenecker W, Reider N, Bangert C. J Clin Med. 2020 Apr 24;9(4):1241. doi: 10.3390/jcm9041241.

• Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis.

Rojahn TB, Vorstandlechner V, Krausgruber T, Bauer WM, Alkon N, Bangert C, Thaler FM, Sadeghyar F, Fortelny N, Gernedl V, Rindler K, Elbe-Bürger A, Bock C, Mildner M, Brunner PM. J Allergy Clin Immunol. 2020 Nov;146(5):1056-1069. doi: 10.1016/j.jaci.2020.03.041. Epub 2020 Apr 25.

• Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.

Rindler K, Jonak C, Alkon N, Thaler FM, Kurz H, Shaw LE, Stingl G, Weninger W, Halbritter F, Bauer WM, Farlik M, Brunner PM. Mol Cancer. 2021 Sep 28;20(1):124. doi: 10.1186/s12943-021-01419-2.

• Single-cell RNA sequencing profiling in a patient with discordant primary cutaneous B-cell and T-cell lymphoma reveals micromilieu-driven immune skewing.

Jonak C, Alkon N, Rindler K, Rojahn TB, Shaw LE, Porkert S, Weninger W, Trautinger F, Stingl G, Tschandl P, Cerroni L, Farlik M, Brunner PM. Br J Dermatol. 2021 Nov;185(5):1013-1025. doi: 10.1111/bjd.20512. Epub 2021 Aug 17.